prednisolone has been researched along with Sphingolipid Storage Diseases in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taube, KM | 1 |
| Beyer, C | 1 |
| Wozniak, KD | 1 |
1 other study available for prednisolone and Sphingolipid Storage Diseases
| Article | Year |
|---|---|
[Importance of lipid metabolism in dermatology].
Topics: Cholesterol; Female; Humans; Hyperlipidemias; Lipid Metabolism; Lipid Metabolism, Inborn Errors; Mal | 1981 |